The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
Neurotransmitter metabolites. Okay, 90% of people we've tested have low levels of dopamine, endorphins, so the whole catakolamine family and serotonin. And this is measured with metabolites in the urine. And so it's called homovanelic acid or HVA for short. You can measure this. And when you talk with someone who is depressed, they're bored easily, they've been diagnosed with ADD or ADHD, they have issues with focus and concentration, we can see the low dopamine on paper.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.